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‘It would have been better if I had HIV 
instead of diabetes’
To the Editor: ‘Go ka bo go ne go le botoka go nna le HIV gona 
le bolwetse jwa sukiri’ (‘It would have been better if I had HIV 
instead of diabetes’). This flippant comment was overheard in a 
diabetes clinic waiting room in southern Botswana earlier this year. 
Although a new diagnosis of diabetes does not carry the stigma of a 
new HIV diagnosis, for many patients it nonetheless feels like a life 
sentence. While there are no local data to support the suggestion 
that type 2 diabetes mellitus (T2DM) confers a worse prognosis 
than HIV, patients with T2DM in Botswana face at least as many 
obstacles to high-quality care as do patients with HIV. 
A network of HIV counselling and testing facilities means that access 
to free, anonymous, same-day HIV testing is available throughout 
Botswana.[1] Despite an estimated prevalence of approximately 11%,[2] 
screening for diabetes is not routinised and most diagnoses are made 
when patients present late in the course of their disease. While 97% 
of Batswana adults have been tested for HIV in the past 12 months,[3] 
more than 80% of patients with T2DM are unaware that they have it.[2]
Notably, there are also stark contrasts in the competence of 
clinicians to manage these diseases. The Ministry of Health has 
had considerable success in building capacity to deliver HIV care 
across the country.[4] Many nurses and doctors are now capable of 
initiating and managing patients on antiretrovirals. In contrast, many 
healthcare providers lack confidence in managing patients with 
advancing diabetes, especially those on insulin therapy. That only two 
oral medications (metformin and glibenclamide) and three insulin 
formulations (Actrapid, Actraphane and Protophane) are available 
on the national formulary also illustrates how T2DM remains under-
prioritised at a policy level.
Disparities in how disease-specific complications are managed 
are also striking. While most HIV-infected patients are screened for 
renal dysfunction and hepatitis before ART initiation and regularly 
thereafter, screening for DM complications occurs far less frequently. 
Furthermore, the diagnostic infrastructure to screen for diabetic 
nephropathy and retinopathy is largely unavailable outside Gaborone. 
The rapid increase in the incidence of diabetes in Botswana is 
cause for alarm,[5] as is the marked lack of clinical capacity to manage 
patients who develop this complex, chronic condition. Botswana has 
had significant success in responding to the HIV epidemic: in excess 
of 90% of eligible individuals are now on antiretrovirals. Lessons 
learnt from this success – leveraging HIV screening strategies and 
capacity building initiatives – are necessary to improve outcomes for 
patients living with T2DM in Botswana. 
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